By Helgi Library - April 2, 2020
Gedeon Richter's total assets reached HUF 749,194 mil at the end of 2015, up 4.05% compared to the previous year. ...
Profit Statement |
Balance Sheet |
Ratios |
Valuation |
Get all company financials in excel:
Get all company financials in excel:
Gedeon Richter Plc. (Richter) is a Hungary-based company specializing in the research, development, production and marketing of pharmaceutical products. The Company focuses in both retail and wholesale market of pharmaceutical products. Its pharmaceutical product range covers therapeutic areas such as cardiovascular, gastrointestinal, gynecology, muscle relaxants, central nervous system and others. Richter has a direct presence in 30 countries with a total of four manufacturing facilities, 14 commercial subsidiaries and wholesalers and 30 representative offices. It sells its pharmaceutical products through its own distribution network to over 100 countries all over the world. Gedeon Richter is headquartered in Budapest, Hungary.
Gedeon Richter has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2015, or of sales. That’s compared to % average margin seen in last five years.
The company netted in 2015 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.
Gedeon Richter’s net debt amounted to at the end of 2015, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.
Gedeon Richter stock traded at per share at the end of 2015 resulting in a market capitalization of . Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2015.